(Q44885167)

7 December 2017

title

Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis (English)

1 reference

7 December 2017

1 reference

Eckhard Schulze-Lohoff

2

object named as

Eckhard Schulze-Lohoff

0 references

author name string

Oliver Gross

1

1 reference

7 December 2017

Eckhard Schulze-Lohoff

2

1 reference

7 December 2017

Marie-Louise Koepke

3

1 reference

7 December 2017

Bogdan Beirowski

4

1 reference

7 December 2017

Klaus Addicks

5

1 reference

7 December 2017

Wilhelm Bloch

6

1 reference

7 December 2017

Neil Smyth

7

1 reference

7 December 2017

Manfred Weber

8

1 reference

7 December 2017

language of work or name

English

0 references

publication date

5 May 2004

1 reference

Nephrology Dialysis Transplantation

7 December 2017

published in

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

1716-1723

1 reference

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Attenuation of atherosclerosis in apolipoprotein E-deficient mice by ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Role for transforming growth factor-beta1 in alport renal disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Proinflammatory actions of angiotensins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Renoprotection: clues from knockout models of rare diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFH219

21 January 2018

Identifiers

DOI

10.1093/NDT/GFH219

1 reference

7 December 2017

1 reference